Travere Therapeutics
TVTX52
$15.97arrow_drop_up1.14%$0.18
High Growth
TVTX52
$15.97
arrow_drop_up1.14%Performance History
There's no data available for key stats
There's no data available for ratios/profitability stats
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Travere Therapeutics (TVTX)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Eric M. Dube Ph.D.
- Headquarters
- San Diego
- Employees
- 462
- Exchange
- NASDAQ
Keep an eye on Travere Therapeutics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.